Analysis of psychotropic medicines triazolam, estazolam and alprazolam mixture using high-performance liquid chromatography method

Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 5

Abstract

Poisoning of benzodiazepines, particularly triazolam, estazolam and alprazolam usually is caused by consumption of the drug in bigger doses than prescribed. So, for the fast determination of material caused poisoning, selective and effective methods of analysis are requested. Methods. Benzodiazepines triazolam, estazolam and alprazolam, were chosen for investigation. Analysis was performed using chromatograph „Waters 2695” with a photodiode array detector (Waters 996, at wavelength 200-400 nm range), ACE C18 (2,1 mm x 5,0 cm, 5 μm) chromatographic column, gradient eluent flow (sulfuric acid buffer 0,1% and ACN), eluent flow rate 0,1 ml/min and injection volume of 10 µl. Results. Methodics for identification and quantification of triazolam, estazolam, alprazolam and their mixture was developed using reference solutions. Validated methodic was adapted for identification and quantification of triazolam, estazolam, alprazolam in medicinal products. Conclusions. Selected methodic is suitable for qualification and quantification of the medicinal preparations: ACE C18 (2,1 mm x 5,0 cm, 5 μm) chromatographic column, gradient eluent flow (sulfuric acid buffer 0,1% and ACN), eluent flow rate 0,1 ml/min, injection volume of 10 µl and diode array detector. Mixture of components has been examined and retention times have been stated as follows: alprazolam (13,216 min), estazolam (13,407 min) and triazolam (14,340 min). Retention time upon repetition of analysis have not exceeded the relative error of p <0,05 limitation. Limits of detection of alprazolam is 0,01 µg/ml, estazolam 0,012 µg/ml, triazolam 0,020 µg/ml. Limit of quantification of alprazolam is 0, 022 µg/ml, estazolam 0, 025 µg/ml, triazolam 0, 045 µg/ml

Authors and Affiliations

Yelyzaveta Kravchuk, Mindaugas Marksa, Augusta Zevzikoviene, Andrejus Zevzikovas

Keywords

Related Articles

Phytochemical study and determination of pharmacological activities of cherry shoots dry extract

<p class="Default"><strong>Aim. </strong>The aim of our research was investigation of phenolic constituents, free and connected sugars of the cherry shoots dry extract by the HPLC method and determination of acute toxici...

Study of the inulin complex of dahlia root bulbs of Ken's flame species and its standardization

<p>The literature data analysis has shown that phytopolysaccharides are perspective sources for study and development of active pharmaceutical ingredients, and can be used as new medicines or biologically active additive...

Analysis of factors that influence on organization of educational and production practice in preparation of pharmacy specialists

<p><strong>The aim: </strong>The aim of the study is to group and analyze external and internal factors that influence on the process of organization of educational and production practices as a component of professional...

Development of composition and technology of combination drug with neurally mediated action «Memofit»

<p> </p><p><strong>Aim. </strong>The aim of this work is to<strong> </strong>develop composition of combination drug in the form of hard-gelatin capsules «Memofit», determine technological and microbiological parameters...

Search of the promising species of subfamily Amygdaloideae and Pyroideae using the chemotaxonomy

<p>World flora has more than 1000 species of the genus Сrataegus L., more than 30 species belong to the subgenus Prunus L., genus Malus Mill. has 100 species, subgenus Cerasus Juss. includes more than 150 species. Despit...

Download PDF file
  • EP ID EP647912
  • DOI 10.15587/2519-4852.2018.146364
  • Views 151
  • Downloads 0

How To Cite

Yelyzaveta Kravchuk, Mindaugas Marksa, Augusta Zevzikoviene, Andrejus Zevzikovas (2018). Analysis of psychotropic medicines triazolam, estazolam and alprazolam mixture using high-performance liquid chromatography method. ScienceRise: Pharmaceutical Science, 0(5), 4-9. https://www.europub.co.uk/articles/-A-647912